Product Information
EVEXITHROID 30 MG TABLET is a generic product labeled by Trifluent Pharma LLC, priced at $0.5917 per EA under NDC 73352069410. Its NADAC has been published 37 times since Jan 21, 2026.
Strength
19; 4.5 ug/1; ug/1
Manufacturer
Trifluent Pharma LLCNDC
73352069410
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOTHYROXINE; LIOTHYRONINEApproval Type
Unapproved
On Market Since
10/12/2025
Pharmacological Classes
Price Statistics
The NADAC for EVEXITHROID 30 MG TABLET has been published 37 times since Jan 21, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5917 per EA |
|---|---|
| All-time high | $0.5962 (Sep 16, 2026) |
| All-time low | $0.5842 (Jan 21, 2026) |
| 52-week high | $0.5962 |
| 52-week low | $0.5842 |
| Median price | $0.5913 |
| Average price | $0.5911 |
| Largest weekly change | +1.3% (Jun 17, 2026) |
| Weeks tracked | 37 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LEVOTHYROXINE and LIOTHYRONINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Trifluent Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LEVOTHYROXINE and LIOTHYRONINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
l-Thyroxine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EVEXITHROID 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEXITHROID 30 MG TABLET, manufactured by Trifluent Pharma LLC, is $0.5917 per EA (NDC 73352069410), effective Sep 30, 2026.
How has the price of EVEXITHROID 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEXITHROID 30 MG TABLET has held within roughly two percent of its current level. It has been tracked across 37 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for EVEXITHROID 30 MG TABLET?
Since Jan 21, 2026, the NADAC for EVEXITHROID 30 MG TABLET has ranged from a low of $0.5842 (Jan 21, 2026) to a high of $0.5962 (Sep 16, 2026), with a median of $0.5913 per EA.
Are there cheaper alternatives to EVEXITHROID 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of EVEXITHROID 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EVEXITHROID 30 MG TABLET?
EVEXITHROID 30 MG TABLET (NDC 73352069410) is labeled by Trifluent Pharma LLC, and CMS classifies it as a generic product.